ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Dementia Charity Readies R&D Network

by Lisa M. Jarvis
February 23, 2015 | APPEARED IN VOLUME 93, ISSUE 8

Research charity Alzheimer’s Research UK has put $46 million toward the launch of Drug Discovery Alliance, a network of academic institutes devoted to early-stage dementia R&D. The first three universities to sign on are the Universities of Cambridge and Oxford and University College London. Each institute will have a chief scientific officer who will work with academic scientists and the charity’s in-house research team. The charity aims to woo 90 world-class researchers into the field over the next five years.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment